| Product Code: ETC7657881 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary  | 
2 Introduction  | 
2.1 Key Highlights of the Report  | 
2.2 Report Description  | 
2.3 Market Scope & Segmentation  | 
2.4 Research Methodology  | 
2.5 Assumptions  | 
3 Israel Orexin Receptor Antagonists Market Overview  | 
3.1 Israel Country Macro Economic Indicators  | 
3.2 Israel Orexin Receptor Antagonists Market Revenues & Volume, 2021 & 2031F  | 
3.3 Israel Orexin Receptor Antagonists Market - Industry Life Cycle  | 
3.4 Israel Orexin Receptor Antagonists Market - Porter's Five Forces  | 
3.5 Israel Orexin Receptor Antagonists Market Revenues & Volume Share, By Dosage, 2021 & 2031F  | 
3.6 Israel Orexin Receptor Antagonists Market Revenues & Volume Share, By Drugs, 2021 & 2031F  | 
3.7 Israel Orexin Receptor Antagonists Market Revenues & Volume Share, By Application, 2021 & 2031F  | 
3.8 Israel Orexin Receptor Antagonists Market Revenues & Volume Share, By End-Users, 2021 & 2031F  | 
4 Israel Orexin Receptor Antagonists Market Dynamics  | 
4.1 Impact Analysis  | 
4.2 Market Drivers  | 
4.2.1 Increasing prevalence of sleep disorders in Israel  | 
4.2.2 Growing awareness about the benefits of orexin receptor antagonists in treating sleep disorders  | 
4.2.3 Rising investments in healthcare infrastructure and research and development in Israel  | 
4.3 Market Restraints  | 
4.3.1 Stringent regulatory requirements for drug approval in Israel  | 
4.3.2 Limited availability of orexin receptor antagonists in the market  | 
4.3.3 High costs associated with the development and production of orexin receptor antagonists  | 
5 Israel Orexin Receptor Antagonists Market Trends  | 
6 Israel Orexin Receptor Antagonists Market, By Types  | 
6.1 Israel Orexin Receptor Antagonists Market, By Dosage  | 
6.1.1 Overview and Analysis  | 
6.1.2 Israel Orexin Receptor Antagonists Market Revenues & Volume, By Dosage, 2021- 2031F  | 
6.1.3 Israel Orexin Receptor Antagonists Market Revenues & Volume, By 5mg, 2021- 2031F  | 
6.1.4 Israel Orexin Receptor Antagonists Market Revenues & Volume, By 10mg, 2021- 2031F  | 
6.1.5 Israel Orexin Receptor Antagonists Market Revenues & Volume, By 15mg, 2021- 2031F  | 
6.1.6 Israel Orexin Receptor Antagonists Market Revenues & Volume, By 20mg, 2021- 2031F  | 
6.2 Israel Orexin Receptor Antagonists Market, By Drugs  | 
6.2.1 Overview and Analysis  | 
6.2.2 Israel Orexin Receptor Antagonists Market Revenues & Volume, By Suvorexant, 2021- 2031F  | 
6.2.3 Israel Orexin Receptor Antagonists Market Revenues & Volume, By Lemborexant, 2021- 2031F  | 
6.2.4 Israel Orexin Receptor Antagonists Market Revenues & Volume, By Others, 2021- 2031F  | 
6.3 Israel Orexin Receptor Antagonists Market, By Application  | 
6.3.1 Overview and Analysis  | 
6.3.2 Israel Orexin Receptor Antagonists Market Revenues & Volume, By Insomnia, 2021- 2031F  | 
6.3.3 Israel Orexin Receptor Antagonists Market Revenues & Volume, By Depression, 2021- 2031F  | 
6.3.4 Israel Orexin Receptor Antagonists Market Revenues & Volume, By Anxiety, 2021- 2031F  | 
6.3.5 Israel Orexin Receptor Antagonists Market Revenues & Volume, By Others, 2021- 2031F  | 
6.4 Israel Orexin Receptor Antagonists Market, By End-Users  | 
6.4.1 Overview and Analysis  | 
6.4.2 Israel Orexin Receptor Antagonists Market Revenues & Volume, By Hospitals, 2021- 2031F  | 
6.4.3 Israel Orexin Receptor Antagonists Market Revenues & Volume, By Homecare, 2021- 2031F  | 
6.4.4 Israel Orexin Receptor Antagonists Market Revenues & Volume, By Speciality Centres, 2021- 2031F  | 
6.4.5 Israel Orexin Receptor Antagonists Market Revenues & Volume, By Others, 2021- 2031F  | 
7 Israel Orexin Receptor Antagonists Market Import-Export Trade Statistics  | 
7.1 Israel Orexin Receptor Antagonists Market Export to Major Countries  | 
7.2 Israel Orexin Receptor Antagonists Market Imports from Major Countries  | 
8 Israel Orexin Receptor Antagonists Market Key Performance Indicators  | 
8.1 Number of clinical trials conducted for orexin receptor antagonists in Israel  | 
8.2 Adoption rate of orexin receptor antagonists by healthcare providers in Israel  | 
8.3 Patient satisfaction and improvement in sleep quality after using orexin receptor antagonists  | 
9 Israel Orexin Receptor Antagonists Market - Opportunity Assessment  | 
9.1 Israel Orexin Receptor Antagonists Market Opportunity Assessment, By Dosage, 2021 & 2031F  | 
9.2 Israel Orexin Receptor Antagonists Market Opportunity Assessment, By Drugs, 2021 & 2031F  | 
9.3 Israel Orexin Receptor Antagonists Market Opportunity Assessment, By Application, 2021 & 2031F  | 
9.4 Israel Orexin Receptor Antagonists Market Opportunity Assessment, By End-Users, 2021 & 2031F  | 
10 Israel Orexin Receptor Antagonists Market - Competitive Landscape  | 
10.1 Israel Orexin Receptor Antagonists Market Revenue Share, By Companies, 2024  | 
10.2 Israel Orexin Receptor Antagonists Market Competitive Benchmarking, By Operating and Technical Parameters  | 
11 Company Profiles  | 
12 Recommendations  | 
13 Disclaimer  |